FSD Pharma announced that the company has retained Christian Attar Law, a regional litigation firm located in Houston, Texas, to co-lead, along with Alan M. Pollack of the New York City law firm Warshaw Burstein, an investigation of any potential naked short selling or other market manipulation of common shares of FSD Pharma. The company and its legal team intend to provide all evidence of and records of activity to the appropriate authorities.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on HUGE:
- FSD Pharma appoints Zeeshan Saeed as CEO
- InvestmentPitch Media Video Discusses FSD Pharma’s Granting of Exclusive Rights to Revolutionary Recreational Alcohol Misuse Technology to Celly Nutrition
- FSD Pharma enters LOI with Celly Nutrition
- FSD Pharma to grant exclusive rights for alcohol misuse technology
- InvestmentPitch Media Video Discusses FSD Pharma’s Cost Award of $2.81 Million from Dr. Raza Bokhari in an Arbitration Settlement